Table 2 Results of randomised controlled trial of nicotine versus placebo patches.
| Randomised to active treatment | Randomised to placebo treatment | |
|---|---|---|
| Total numbers | 49 | 49 |
| Mean age in years | 14.9 | 14.7 |
| Percentage female | 64 | 56 |
| Median exhaled CO (ppm) | 12.9 | 11.8 |
| CO validated point abstinence at 4 weeks | 5 | 4 |
| CO validated point abstinence at 13 weeks | 0 | 0 |
| Completed full six week treatment course | 3 | 5 |
| Withdrew because of adverse event | 1 | 1 |
| Other non‐severe adverse events* | ||
| Itching | 16 | 7 |
| Rash | 6 | 3 |
| Pain or paraesthesia at patch site | 6 | 4 |
| Dizziness, nausea or headache | 2 | 3 |
*Some participants experienced more than one adverse effect.
CO, carbon monoxide.